Document:

Exhibit 4.94

 

Summary of the Rural Partnership Agreement,
entered into on May 25, 2022, in connection with Fazenda Regalito.

 

Parties:
BrasilAgro – Companhia Brasileira de Propriedades Agrícolas, as the economic group interested in entering into a rural partnership
agreement; and with Luiz Alfredo Feresin de Abreu, as the owner of the land.

 

Purpose: Granting
of the possession, for twelve years, counted as of June 1, 2022 (commencement date of the term), of a total area equivalent to 5,714 arable
hectares of Regalito Farm on behalf of BrasilAgro – Companhia Brasileira de Propriedades Agrícolas, for
purposes of the exploitation of the land under a rural partnership regime, by means of the sharing, by and among the parties, of the earnings
received from the crops/harvests arising from the aforementioned partnership. BrasilAgro – Companhia Brasileira de Propriedades
Agrícolas shall be entitled to approximately 83.5% of the earnings, and Luiz Alfredo Feresin de Abreu shall be entitled to the
remaining 16.5% of the earnings therefrom.Exhibit 4.95

 

Summary of the Rural Lease Agreement, entered
into on April 9, 2020, in connection with Fazenda Nossa Senhora Aparecida.

 

Parties:
BrasilAgro – Companhia Brasileira de Propriedades Agrícolas, as the economic group interested in entering into a rural lease
agreement; and Ademar Dias de Oliveira, as the owner of the land.

 

Purpose: Granting
of the possession, for the period of six years, counted as of August 19, 2022 (commencement date of the term), of a total area equivalent
to 2,100 arable hectares. The lease payments for the land use were agreed as 33,600 bags of soybean per year, net of taxes.Exhibit 4.96

 

Summary of the Private Instrument of Commitment
to Purchase and Sale of Real Properties, entered into on September 1, 2021, in connection with Fazenda São Simão.

 

Parties:
Agrifirma Bahia Agropecuária Ltda., as Seller; Francisco Ferreira Camacho, as buyer; and Brasilagro – Companhia Brasileira
de Propriedades Agrícolas as an intervening/consenting party.

 

Purpose: The
commitment to sell a total area of 4,573.27 hectares, of which 2,859.34 hectares are arable, to be split from the São Simão
Farm, for the total price, in Brazilian reais, equivalent to 714,835 bags of soybeans, to be paid as follows: (i) the first installment
equivalent to 107,224.55 bags of soybeans was paid in on December 30, 2021; (ii) the second installment equivalent to 21,445.84 bags of
soybeans was paid on June 10, 2022; (iii) the third installment equivalent to 14.296.61 bags of soybeans, shall be paid on October 24,
2022; (iv) the fourth installment equivalent to 57.187.36 bags of soybeans, shall be paid on June 10, 2023; (v) the fifth installment
equivalent to 50,039.05 bags of soybeans, shall be paid on October 10, 2023; (vi) the sixth installment equivalent to 85,779.64 bags of
soybeans, shall be paid on June 10, 2024; (vii) the seventh installment equivalent to 78,631.34 bags of soybeans, shall be paid on October
10, 2024; (viii) the eighth installment equivalent to 85,779.64 bags of soybeans, shall be paid in June 10, 2024; (ix) the ninth installment
equivalent to 78,631.34 bags of soybeans, shall be paid on October 10, 2025; (ix) the tenth installment equivalent to 50,038.13 bags of
soybeans, shall be paid on June 10, 2026; (x) the tenth installment equivalent to 50,038.13 bags of soybeans, shall be paid in June 10,
2026; (xi) the eleventh installment equivalent to 42,889.82 bags of soybeans, shall be paid in October 10, 2026; (xii) the twelfth installment
equivalent to 21,445.84 bags of soybeans, shall be paid in June 10, 2027; and (xiii) the thirteenth installment equivalent to 21,445.84
bags of soybeans, shall be paid in October 10, 2027.Exhibit 4.97

 

Summary of the Private Instrument of Commitment
to Purchase and Sale of Real Properties, entered into on September 1, 2021, in connection with Fazenda Alto Taquari.

 

Parties:
Imobiliária Mogno Ltda., as seller; Victor Cezar Priori and Tania Janete Priori, as buyers.

 

Purpose: The
commitment to sell a total area of 3,723 hectares, of which 2,694 hectares are arable, to be split from the Alto Taquari Farm,
for the total price, in Brazilian reais, equivalent to 2,962,974 bags of soybeans, to be paid as follows: (i) the first installment
equivalent to 290,000 bags of soybeans was paid in on October 10, 2021; (ii) the second installment equivalent to 290,000 bags of soybeans
was paid on May 31, 2022; (iii) the third installment equivalent to 290,000 bags of soybeans, shall be paid on May 30, 2023; (iv) the
fourth installment equivalent to 290,000 bags of soybeans, shall be paid on May 30, 2024; (v) the fifth installment equivalent to 346,000
bags of soybeans, shall be paid on May 30, 2025; (vi) the sixth installment equivalent to 346,000 bags of soybeans, shall be paid on May
30, 2026; (vii) the seventh installment equivalent to 346,000 bags of soybeans, shall be paid on May 30, 2027; (viii) the eighth installment
equivalent to 346,000 bags of soybeans, shall be paid in May 30, 2028; and (ix) the ninth installment equivalent to 418,974 bags of soybeans,
shall be paid on May 30, 2029.Exhibit 4.98

 

Summary of the Instrument of Commitment
to Purchase and Sale of Real Properties, entered into on September 15, 2021, in connection with Fazenda Panamby.

 

Parties:
Kng Administração e Participações Ltda., Tritt Administração e Participações Ltda.,
Terra-Azul Organização Administrativa Ltda. e SBR Administração e Participações Ltda., as sellers; Imobiliária
Mogno Ltda., as buyer.

 

Purpose: The
commitment to buy the Panamby Farm with a total area of 10,792 hectares, of which 5,379 hectares are arable. The acquisition value
is R$285.6 million (302 soybean bags per arable hectare), to be paid in two installments, comprised of a down-payment in the amount of
R$140.0 million, which was paid in September 2022, and an additional installment to be paid in 2023.Exhibit 10.1

 

EMPLOYMENT
AGREEMENT

 

THIS EMPLOYMENT
AGREEMENT (the “Agreement”) is entered into by and between Odyssey Pharmaceuticals a wholly owned subsidiary of Odyssey
Health Inc (the “Company”) a Nevada Corporation and Erik Emerson (the “Executive”) whose address
is _________________.

 

WHEREAS,
the Company desires to employ the Executive as its Chief Commercial Officer and the Executive desires to serve in such capacity on behalf
of the Company.

 

WHEREAS,
the Company and the Executive desire to enter into this Agreement to set forth the terms and conditions of the employment relationship
between the Company and the Executive;

 

NOW,
THEREFORE, in consideration of the mutual covenants and agreements contained herein, and other good and valuable consideration, the receipt
and sufficiency of which is hereby acknowledged, the parties agree as follows:

 

1.       Employment.

 

(a)
       Term. Executive’s Term of employment (the “Term”) under this
Agreement shall be one (1) year, commencing on November 1, 2022 (the “Effective Date”), and shall continue for a period
through and including November 1, 2023 (the “Initial Term”),

 

(b)       Duties.
During the Term, the Executive shall serve as the Chief Commercial Officer or other job related to the Company with duties, responsibilities
and authority commensurate therewith and shall report to the Chief Executive Officer or his designee (the “CEO”).
The Executive shall perform all duties and accept all responsibilities incident to such position as may be reasonably assigned by the
CEO. The Executive represents to the Company that he is not subject to or a party to any other employment agreement, non-competition
covenant, or other agreement that would be breached by, or prohibit the Executive from executing, this Agreement and performing fully
her duties and responsibilities under this Agreement.

 

(c)       Exclusive
Services. Subject to the permissions and restrictions specified in Section 14 below, Executive agrees to devote energies and skill
to the discharge of the duties and responsibilities attributable to this position, and to this end will devote 33 and 1/3 percent of
business time and attention to the business and affairs of the Company and its affiliated entities. The foregoing shall not be construed
as preventing the Executive from (1) serving on civic, trade association, industry, educational, philanthropic, charitable or non-profit
boards or committees, or, on corporate boards for businesses that are not in competition with the Company, and (2) managing personal
investments, so long as such activities do not conflict with the Company’s published code of conduct and employment policies.

 

(d)       Principal
Place of Employment. The Executive understands and agrees that the Principal Place of Employment will be in the Executive’s
residence and will be required to travel for business in the course of performing the duties for the Company.

 

2.       Compensation.

 

(a)       Base
Salary and Accrued compensation. During the Employment Term, and subject to raising funds, the Company shall pay the Executive a
minimum annual base salary of $125,000 (“Base Salary”) payable in equal installments at such payment intervals as
are the usual custom of the Company, but not less often than monthly. The Base Salary will not begin to be payable until such time that
the Company has raised a cumulative of $5,000,000 in funding. Thereafter the Base Salary will be paid to Executive.

 

 

 

 

    	 	1	 

     

    

 

(c)       Equity
Incentive. Executive will be granted stock options per the Odyssey Health Inc. Stock Option Plan in the amount of six hundred thousand
(600,000) options The exercise price will be the stock’s closing price on the day the Board of directors approve this agreement
and the Stock options. Vesting is as follows:

 

125,000
vest upon signing of this agreement

300,000
vest upon a financing by the Company in the amount of $5,000,000 or more.

175,000
vest upon the listing of the Company on a national exchange such as Nasdaq or the NYSE.

 

In
the event of a Change of Control (as defined in this Section 2(c)) of the Company while you continue to be employed by the Company, stock
options will become fully vested and exercisable. For purposes of this Agreement, a “Change of Control” means that
any of the following events has occurred:

 

(i)       Any
person or entity (as such term is used in Section 13(d) of the Securities Exchange Act of 1934 (the “Exchange Act”)),
other than the Company, any employee benefit plan of the Company or any entity organized, appointed or established by the Company for
or pursuant to the terms of any such plan, together with all “affiliates” and “associates” (as such terms are
defined in Rule 12b-2 under the Exchange Act) becomes the beneficial owner or owners (as defined in Rule 13d-3 and 13d-5 promulgated
under the Exchange Act), directly or indirectly (the “Control Group”), of more than 50% of the outstanding equity
securities of the Company, or otherwise becomes entitled, directly or indirectly, to vote more than 50% of the voting power entitled
to be cast at elections for directors (“Voting Power”) of the Company;

 

(ii)       A
consolidation or merger (in one transaction or a series of related transactions) of the Company pursuant to which the holders of the
Company’s equity securities immediately prior to such transaction or series of related transactions would not be the holders, directly
or indirectly, immediately after such transaction or series of related transactions of more than 50% of the Voting Power of the entity
surviving such transaction or series of related transactions;

 

(iii)       The
sale, lease, exchange or other transfer (in one transaction or a series of related transactions) of all or substantially all of the assets
of the Company; or

 

(iv)       The
liquidation or dissolution of the Company or the Company ceasing to do business.

 

3.       Benefit
Plans. During the Employment Term, and as otherwise provided herein, but at the Company’s sole discretion, Executive shall
be able to participate in any and all employee welfare and health benefit plans (including, but not limited to, life insurance, health,
dental, and disability plans) and other employee benefit plans, including, but not limited to, qualified pension plans, established by
the Company from time-to-time for the benefit of all executives of the Company. Executive shall be required to comply with the conditions
attendant to coverage by such plans and shall comply with and be entitled to benefits only in accordance with the terms and conditions
of such plans as they may be amended from time-to-time. Nothing contained in this Agreement shall be construed as requiring the Company
to establish or continue any particular benefit plan in discharge of its obligations under this Agreement or preclude the Company or
any affiliate of the Company from terminating or amending any employee benefit plan or program from time-to-time after the Effective
Date.

 

5.       Expenses.
The Company shall pay or reimburse the Executive for all reasonable, ordinary, and necessary business expenses incurred by the Executive
in the performance of the responsibilities and the promotion of the Company’s businesses. All expenses must be pre-approved in
writing by the Company. The Executive shall submit to the Company periodic statements of all expenses so incurred. Subject to such reasonable
accounting procedures as the Company may adopt generally from time-to-time for executives, the Company shall reimburse the Executive
the full amount of any such expenses advanced by him in the ordinary course of business. The Company shall reimburse the Executive for
travel to/from the Principal Place of Employment including food and lodging, together
with reasonable dues and related expenses for industry associations and groups, publications, required professional training and similar
activities. All such expenses must be pre-approved in writing by the Company and reimbursement of expenses shall be paid within
fifteen (15) days of submitting receipts for such expenses.

 

 

 

    	 	2	 

     

    

 

6.       Termination
.. The Company may terminate the Executive’s employment at any time. Executive may terminate Employment at any time. No severance
will be paid to Executive upon termination.

 

11.       Resignation
of Positions. Effective as of the date of any termination of employment, the Executive will resign all Company-related positions,
including as an officer of the Company and its parents, subsidiaries and affiliates.

 

13.       Section
409A.

 

(a)                  
This Agreement is intended to comply with Section 409A of the Internal Revenue
Code of 1986, as amended (the “Code”) and its corresponding regulations, or an exemption, and payments may only be
made under this Agreement upon an event and in a manner permitted by Code § 409A of the Code, to the extent applicable. Severance
benefits under the Agreement are intended to be exempt from Code § 409A under the “short-term deferral” exception, to
the maximum extent applicable, and then under the “separation pay” exception, to the maximum extent applicable. Notwithstanding
anything in this Agreement to the contrary, if required by Code § 409A, if the Executive is considered a “specified employee”
for purposes of Code § 409A and if payment of any amounts under this Agreement is required to be delayed for a period of six months
after separation from service pursuant to Code § 409A, payment of such amounts shall be delayed as required by Code § 409A,
and the accumulated amounts shall be paid in a lump-sum payment within ten days after the end of the six-month period. If the Executive
dies during the postponement period prior to the payment of benefits, the amounts withheld on account of Code § 409A shall be paid
to the personal representative of the Executive’s estate within 60 days after the date of the Executive’s death.

 

(b)                 
All payments to be made upon a termination of employment under this Agreement
may only be made upon a “separation from service” under Code § 409A. For purposes of Code § 409A, each payment
hereunder shall be treated as a separate payment and the right to a series of installment payments under this Agreement shall be treated
as a right to a series of separate payments. In no event may the Executive, directly or indirectly, designate the calendar year of a
payment. Notwithstanding any provision of this Agreement to the contrary, in no event shall the timing of the Executive’s execution
of the Release, directly or indirectly, result in the Executive designating the calendar year of payment of any amounts of deferred compensation
subject to Code § 409A, and if a payment that is subject to execution of the Release could be made in more than one taxable year,
payment shall be made in the later taxable year.

 

(c)                  
All reimbursements and in-kind benefits provided under the Agreement shall
be made or provided in accordance with the requirements of Code § 409A, including, where applicable, the requirement that (i) any
reimbursement is for expenses incurred during the period of time specified in this Agreement, (ii) the amount of expenses eligible for
reimbursement, or in-kind benefits provided, during a calendar year may not affect the expenses eligible for reimbursement, or in-kind
benefits to be provided, in any other calendar year, (iii) the reimbursement of an eligible expense will be made no later than the last
day of the calendar year following the year in which the expense is incurred, and (iv) the right to reimbursement or in-kind benefits
is not subject to liquidation or exchange for another benefit.

 

14.       Restrictive
Covenants. Executive acknowledges that her position with the Company is special, unique, and intellectual in character, that in her
position she will have special access to and knowledge about Company plans, strategies, intellectual property including trade secrets
and know-how, and that her position in the Company will place him in a position of confidence and trust with employees and clients of
the Company. For this reason, Executive agrees that the provisions set forth below in this Section 14 are fair and reasonable to the
Company, its shareholders, and the Executive.

 

(a)                    
Non-Solicitation of Company Personnel. During the Term and during the
Restriction Period, the Executive hereby agrees that the Executive will not, either directly or through others, hire or attempt to hire
any employee, consultant or independent contractor of the Company or its Affiliates, other than an Officer or Director of the Company,
or solicit or attempt to solicit any such person to change or terminate her relationship with the Company or an Affiliate or otherwise
to become an employee, consultant or independent contractor to, for or of any other person or business entity, unless more than two (2)
months shall have elapsed between the last day of such person’s employment or service with the Company or Affiliate and the first
date of such solicitation or hiring or attempt to solicit or hire. The provisions of this subsection (b) shall not apply to general employment
advertisements, job fairs and other general public solicitations seeking to hire personnel.

 

 

    	 	3	 

     

    

 

(b)                    
Non-Solicitation of Customers. During the Term and during the Restriction
Period, the Executive hereby agrees that the Executive will not, either directly or through others, solicit, divert or appropriate, or
attempt to solicit, divert or appropriate any customer or prospective customer for which the Company has prepared written proposals for
the purpose of providing such customer or prospective customer with services or products directly competitive with those offered by the
Company or an Affiliate during the Term.

 

(c)                    
Proprietary Information. Executive acknowledges that Executive will
have access to certain proprietary and confidential information of the Company and its customers and vendors (collectively “Proprietary
Information”). At all times, during the Term of this Agreement, the Executive will hold in strictest confidence and will not disclose,
use, lecture upon or publish any of the Proprietary Information (defined below) of the Company or an Affiliate, except as such disclosure,
use or publication may be required in connection with the Executive’s work for the Company in accordance with this Agreement or
as described in Section 14(e) below, or unless the Company expressly authorizes such disclosure in writing. “Proprietary Information”
shall mean any and all confidential and/or proprietary knowledge, data or information of the Company and its Affiliates and shareholders,
including but not limited to written information relating to financial matters, investments, budgets, business plans, sales projections,
cost, pricing and pricing models, marketing and advertising plans, creative campaigns and themes, personnel matters, business contacts,
products and contemplated new products and services, processes, know-how, designs, methods, improvements, discoveries, inventions, ideas,
data, programs, and other works of authorship that are in writing and marked “Confidential”.

 

(d)                    
Reports to Government Entities. Nothing in this Agreement shall prohibit
or restrict the Executive from initiating communications directly with, responding to any inquiries from, providing testimony before,
providing confidential information to, reporting possible violations of law or regulation to, or from filing a claim or assisting with
an investigation directly with a self-regulatory authority or a government agency or entity, including the U.S. Equal Employment Opportunity
Commission, the Federal Drug Administration, the Department of Labor, the National Labor Relations Board, the Department of Justice,
the Securities and Exchange Commission, the United States Congress, and any agency Inspector General (collectively, the “Regulators”),
or from making other disclosures that are protected under the whistleblower provisions of state or federal law or regulation. The Executive
does not need the prior authorization of the Company to engage in such communications, respond to such inquiries, provide confidential
information or documents to the Regulators, or make any such reports or disclosures to the Regulators. The Executive is not required
to notify the Company that the Executive has engaged in such communications with the Regulators. If the Executive is required by law
to disclose Proprietary Information, other than to Regulators as described above, the Executive shall give prompt written notice to the
Company so as to permit the Company to protect its interests in confidentiality to the extent possible.

 

(f)                       
Invention Assignment. The Executive agrees that all inventions, innovations,
improvements, developments, methods, designs, analyses, reports, and all similar or related information which relates to the Company’s
or its Affiliates’ actual or anticipated business, research and development or existing or future products or services and which
are conceived, developed, created, or made by Executive, alone or with others, whether or not patentable, registerable, or copyrightable,
while employed by the Company (“Work Product”) belong to the Company. The Executive will promptly disclose such Work
Product to the Board and perform all actions reasonably requested by the Board (whether during or after the Term) to establish and confirm
such ownership (including, without limitation, assignments, consents, powers of attorneys, applications for and procuring patents, trademarks,
service marks, or copyrights, and other instruments as the Company, in its sole discretion, may request). Executive agrees to give the
Company all assistance it may reasonably require, including the giving of testimony in any suit, action, investigation, or other proceeding,
to obtain, maintain, and protect the Company’s rights in the Work Product. Executive agrees as a condition of employment to sign
and be bound by the Company’s standard Inventions Assignment Agreement. The parties agree that the inventions listed in Exhibit
A to this Agreement, which is incorporated in and made a substantive part of this Agreement, are excluded from the application of this
subsection (f).

 

(g)                      
Return of Company Property. All records, files, lists, including computer
generated lists, drawings, documents, equipment, and similar items relating to the Company’s business that Executive shall prepare
or receive from the Company shall remain the Company’s sole and exclusive property. Upon termination of the Executive’s
employment with the Company for any reason, voluntarily or involuntarily, and at any earlier time the Company requests, the Executive
will deliver to the person designated by the Company all originals and copies of all documents and property of the Company or an Affiliate
that is in the Executive’s possession, under the Executive’s control or to which the Executive may have access. The Executive
shall keep one copy of all items related to the Company’s business listed above in this paragraph.

 

 

 

    	 	4	 

     

    

 

(h)                    
The foregoing provisions of subsections (a), (b), (c), and (d) shall not apply
to the company or companies listed in Exhibit B, as may amended from time-to-time by signed written agreement of the Board and Executive,
which exhibit is incorporated in and made a substantive part of this Agreement.

 

(i)                     
Notwithstanding anything in this Agreement to the contrary, and in addition
to any other lawful rights and remedies available to the Company, if the Executive breaches any of the Executive’s obligations
under Section 14, the Company shall be obligated to provide only the compensation and accrued benefits required by any Company benefit
plans, policies or practices then applicable to the Executive in accordance with the terms thereof. In such event, the Company may require
that the Executive repay all amounts theretofore paid to him pursuant to Section 6 hereof; and in such case, the Executive shall promptly
repay such amounts on the terms determined by the Company up to a maximum of fifty thousand dollars ($50,000.00).

 

(j)                        
The provisions of this Section 14 and Section 15 below shall survive any termination
of the Executive’s employment or the termination or expiration of this Agreement for a period of six months.

 

15.       Legal
and Equitable Remedies.

 

(a)                    
Because
the Executive’s services are personal and unique and the Executive has had and will continue to have access to and has become and
will continue to become acquainted with the proprietary information of the Company and its Affiliates, and because any breach by the
Executive of any of the restrictive covenants contained in Section 14 would result in irreparable injury and damage for which money damages
would not provide an adequate remedy, the Executive agrees that Company shall have the right to enforce Section 14 and any of its provisions
by injunction, specific performance or other equitable relief, without bond and without prejudice to any other rights and remedies that
the Company may have for a breach, or threatened breach, of the restrictive covenants set forth in Section 14. The Executive expressly
consents to enforcement of Section 14 by means of temporary or permanent injunction and other appropriate equitable relief in any competent
court or arbitration tribunal, and agrees that in any action in which the Company seeks injunction, specific performance or other equitable
relief, the Executive will not assert or contend that any of the provisions of Section 14 are unreasonable or otherwise unenforceable.

 

(b)                    
Any and all disputes arising under or relating to the interpretation or application
of this Agreement or concerning Executive’s employment with the Company or termination of employment shall be subject to final
and binding arbitration in the Chicago, Illinois under the then existing rules of the American Arbitration Association relating to employment
matters. Judgment upon the award rendered may be entered in any court of competent jurisdiction. The cost of arbitration and Executive’s
legal expenses shall be borne by the Company. Nothing contained in this subsection (b) shall limit the right of the Company to enforce
by court injunction or other equitable relief the Executive’s obligations under Section 14. In any court proceeding arising out
of this Agreement, the parties (1) irrevocably consent to the exclusive jurisdiction of the United States District Court for Northern
District of Illinois or if such court does not have jurisdiction or will not accept jurisdiction, to any court of general jurisdiction
in Illinois and (2) waive any objection to the laying of venue of any such proceeding in any such court.

 

(c)               
Indemnification. In addition to any rights Executive may have under
the Company's charter or by-laws, the Company agrees to indemnify Executive and hold Executive harmless, both during the Term and after
the Term or Termination for any reason, of this Agreement, against all costs, expenses (including, without limitation, fines, taxes and
attorneys' and accountants’ fees) and liabilities (collectively, "Losses") reasonably incurred by Executive in connection
with any claim, action, proceeding or investigation brought against or involving Executive with respect to, arising out of or in any
way relating to Executive's employment with the Company or Executive's service as a director of the Company. Executive shall promptly
notify the Company of any claim, action, proceeding or investigation under this paragraph and the Company shall be entitled to participate
in the defense of any such claim, action, proceeding or investigation and, if it so chooses, to assume the defense with counsel selected
by the Company; provided that Executive shall have the right to employ counsel to represent him (at the Company's expense) if Company
counsel would have a "conflict of interest" in representing both the Company and Executive. The Company shall not settle or
compromise any claim, action, proceeding or investigation without Executive's consent, which consent shall not be unreasonably withheld;
provided, however, that such consent shall not be required if the settlement entails only the payment of money and the Company fully
indemnifies Executive in connection therewith. The Company further agrees to advance any and all expenses (including, without limitation,
the fees and expenses of counsel) reasonably incurred by the Executive in connection with any such claim, action, proceeding or investigation.
The Company, as soon as reasonably possible, will maintains a policy of directors' and officers' liability insurance covering Executive
and, notwithstanding the expiration or earlier termination of this Agreement, the Company shall maintain a directors' and officers' liability
insurance policy covering Executive for a period of time following such expiration or earlier termination equal to the statute of limitations
for any claim that may be asserted against Executive for which coverage is available under such directors' and officers' liability insurance
policy. All provisions of this paragraph shall survive the termination of this Agreement for any reason.

 

 

    	 	5	 

     

    

 

16.       Survival.
The respective rights and obligations of the parties under this Agreement, including, but not limited to, Sections 14 and 15, shall
survive any termination of the Executive’s employment or termination or expiration of this Agreement to the extent necessary to
the intended preservation of such rights and obligations.

 

17.       No
Mitigation or Set Off. In no event shall the Executive be obligated to seek other employment or take any other action by way of mitigation
of the amounts payable to the Executive under any of the provisions of this Agreement and such amounts shall not be reduced, regardless
of whether the Executive obtains other employment. During the pendency of any claim between the Company and Executive, the Company’s
obligation to make the payments provided for in this Agreement and otherwise to perform its obligations hereunder with respect to any
set-off, counterclaim, recoupment, defense or other right which the Company may have against the Executive or others, may be determined
on an interlocutory basis by a competent court or arbitration tribunal.

 

18.       Notices.
All notices and other communications required or permitted under this Agreement or necessary or convenient in connection herewith
shall be in writing and shall be deemed to have been given when hand delivered or mailed by registered or certified mail, as follows
(provided that notice of change of address shall be deemed given only when received):

 

If
to the Company, to:

 

Odyssey
Health, Inc.

 

Las
Vegas, NV

Attention:
CEO

 

If
to the Executive, to the most recent address on file with the Company or to such other names or addresses as the Company or the Executive,
as the case may be, shall designate by notice to each other person entitled to receive notices in the manner specified in this Section.

 

19.       Withholding.
All payments under this Agreement shall be made subject to applicable tax withholding, and the Company shall withhold from any payments
under this Agreement all federal, state and local taxes as the Company is required to withhold pursuant to any law or governmental rule
or regulation.

 

20.       Remedies
Cumulative; No Waiver. No remedy conferred upon a party by this Agreement is intended to be exclusive of any other remedy, and each
and every such remedy shall be cumulative and shall be in addition to any other remedy given under this Agreement or now or hereafter
existing at law or in equity. No delay or omission by a party in exercising any right, remedy or power under this Agreement or existing
at law or in equity shall be construed as a waiver thereof, and any such right, remedy or power may be exercised by such party from time-to-time
and as often as may be deemed expedient or necessary by such party in its sole discretion.

 

21.       Assignment.
All of the terms and provisions of this Agreement shall be binding upon and inure to the benefit of and be enforceable by the respective
heirs, executors, administrators, legal representatives, successors and assigns of the parties hereto, except that the duties and responsibilities
of the Executive under this Agreement are of a personal nature and shall not be assignable or delegable in whole or in part by the Executive.
Successors of the Company shall include, without limitation, any company or companies acquiring, directly or indirectly, all or substantially
all of the assets of the Company, whether by merger, consolidation, purchase, lease, or otherwise, and such successor shall thereafter
be deemed “the Company” for the purpose of this Section 21.

 

22.       Entire
Agreement.

 

(a)                    
This Agreement, including all referenced addendums and exhibits, embodies the entire agreement of the parties with respect to
its subject matter and merges with and supersedes all prior discussions, agreements, commitments, or understandings of every kind and
nature relating to Executive’s employment, whether oral or written, between Executive and the Company. Neither party shall be bound
by any term or condition other than as is expressly set forth in this Agreement.

 

 

 

    	 	6	 

     

    

 

(b)                   
Executive represents and agrees that she fully understands her right to discuss all aspects of this Agreement with her private
attorney, that to the extent she desired Executive availed himself of this right, that Executive has carefully read and fully understands
all of the provisions of the Agreement, that Executive is competent to execute this Agreement, that her decision to execute this Agreement
has not been obtained by any duress, that Executive freely and voluntarily enters into this Agreement, and that Executive has read this
document in its entirety and fully understands the meaning, intent, and consequences of this Agreement.

 

23.       Amendment.
This Agreement may be changed, modified or amended only by a written document signed by the Executive and the Board.

 

24.       Severability.
If any provision of this Agreement or application thereof to anyone or under any circumstances is adjudicated to be invalid or unenforceable
in any jurisdiction, such invalidity or unenforceability shall not affect any other provision or application of this Agreement which
can be given effect without the invalid or unenforceable provision or application and shall not invalidate or render unenforceable such
provision or application in any other jurisdiction. If any provision is held void, invalid or unenforceable with respect to particular
circumstances, it shall nevertheless remain in full force and effect in all other circumstances.

 

25.       Governing
Law. This Agreement and any claims arising out of relating to this Agreement, whether in contract or tort, statutory or common law,
shall be governed exclusively by, and construed in accordance with the laws of the State of Nevada without regard to principles of conflicts
of laws.

 

26.       Forum
Selection and Consent to Jurisdiction. ANY LITIGATION BASED HEREON, OR ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS AGREEMENT,
SHALL BE BROUGHT AND MAINTAINED EXCLUSIVELY IN THE COURTS OF THE STATE OF NEVADA OR IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT
OF NEVADA; THE PARTIES HEREBY EXPRESSLY AND IRREVOCABLY WAIVE, TO THE FULLEST EXTENT PERMITTED BY LAW, ANY OBJECTION WHICH THEY MAY NOW
OR HEREAFTER HAVE TO THE LAYING OF VENUE OF ANY SUCH LITIGATION BROUGHT IN ANY SUCH COURT REFERRED TO ABOVE AND ANY CLAIM THAT ANY SUCH
LITIGATION HAS BEEN BROUGHT IN AN INCONVENIENT FORUM.

 

27.       Waiver
of Jury Trial. EACH PARTY HEREBY WAIVES ANY RIGHT TO A TRIAL BY JURY IN ANY ACTION OR PROCEEDING TO ENFORCE OR DEFEND ANY RIGHTS
UNDER THIS AGREEMENT AND ANY AMENDMENT, INSTRUMENT, DOCUMENT OR AGREEMENT DELIVERED OR WHICH MAY IN THE FUTURE BE DELIVERED IN CONNECTION
HEREWITH OR THEREWITH OR ARISING FROM ANY RELATIONSHIP EXISTING IN CONNECTION WITH ANY OF THE FOREGOING, AND AGREES THAT ANY SUCH ACTION
OR PROCEEDING SHALL BE TRIED BEFORE A COURT AND NOT BEFORE A JURY.

 

28.       Service
of Process: Each party hereto hereby consents to service of process in any action between any of the Parties hereto arising in whole
or in part under or in connection with this Agreement, any document related to, or the negotiation, terms or performance hereof or thereof,
(a) in any manner permitted by Nevada law or (b) by overnight delivery by a nationally recognized courier service at the respective address
specified in this Agreement, and waives and agrees not to assert (by way of motion, as a defense or otherwise) in any such Action any
claim that service of process made in accordance with clause (a) or (b) does not constitute good and valid service of process.

 

29.       Counterparts;
Electronic Transmission. This Agreement may be executed in counterparts, each of which shall be deemed an original, but all of which
together shall be deemed to be one and the same agreement. A signed copy of this Agreement delivered by facsimile, e-mail or other means
of electronic transmission (including an electronically-signed PDF) shall be deemed to have the same legal effect as delivery of an original
signed copy of this Agreement.

 

Read
and Agreed to:

 

Erik Emerson

 

	/s/ Erik Emerson  	 	Date: 11/1/2022

 

 

Odyssey
Pharmaceuticals Inc.

 

	By:	/s/ J. Michael Redmond  	 	Date: 11/1/2022

 

 

    	 	7

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00350-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00350-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00350-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00350-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00350-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00350-of-00352.parquet"}]]